Abstract-Sphingolipids and their metabolic products are now known to have second-messenger functions in a variety of cellular signaling pathways. Lactosylceramide (LacCer), a glycosphingolipid (GSL) present in vascular cells such as endothelial cells, smooth muscle cells, macrophages, neutrophils, platelets, and monocytes, contributes to atherosclerosis. Large amounts of LacCer accumulate in fatty streaks, intimal plaque, and calcified intimal plaque, along with oxidized low density lipoproteins (Ox-LDLs), growth factors, and proinflammatory cytokines. A possible role for LacCer in vascular cell biology was suggested when this GSL was found to stimulate the proliferation in vitro of aortic smooth muscle cells (ASMCs). A further link of LacCer in atherosclerosis was uncovered by the finding that Ox-LDLs stimulated specifically the biosynthesis of LacCer. Ox-LDL-stimulated endogenous synthesis of LacCer by activation of UDP-Gal:GlcCer,1-4galtransferase (GalT-2) is an early step in this signaling pathway. In turn, LacCer serves as a lipid second messenger that orchestrates a signal transduction pathway, ultimately leading to cell proliferation. This signaling pathway includes LacCer-mediated activation of NADPH oxidase that produces superoxide. Such superoxide molecules stimulate the GTP loading of p21 ras . Subsequently, the kinase cascade ( T hudichum 1 first discovered cerebroside from the human brain in 1884. A characteristic component of this and all glycosphingolipids (GSLs) is an aliphatic amino alcohol, sphingosine. Thudichum called this compound sphingosine because of its enigmatic chemical nature (containing both amine and alcohol groups, but insoluble in water), referring to the Sphinx of Greek mythology who posed riddles. Since that time, most of the studies on sphingoglycolipids have been pursued in regard to determining their structure, biosynthesis, and degradation. These compounds might have been forgotten had it not been shown that the inability to catabolize certain GSLs resulted in their accumulation in various tissues, leading to metabolic diseases, 2 collectively called the "glycosphingo-